We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01422811
Recruitment Status : Completed
First Posted : August 24, 2011
Last Update Posted : August 24, 2011
Information provided by (Responsible Party):

Study Description
Brief Summary:
  1. Background: In recent years an increasing trend in excessive lengths of stay has been recorded at the Parma University Hospital, compared with regional mean values. Excessive lengths of stay have been demonstrated to constitute not just an economic problem, but also a clinical and public health issue. Since the measures taken at our institution so far have not proven effective, the investigators carried out a literature review, which mostly detected observational studies, restricted to the assessment of the impact of a single intervention.
  2. Objectives: This project intends to evaluate the effectiveness of a multifaceted strategy aiming to empower clinicians on the issues associated with excessively long and avoidable hospital stays, and enable them to identify corrective measures (according to the principles of clinical governance).
  3. Study design: cluster-randomized, parallel group, open-label, community trial
  4. Methods: trained personnel will periodically record causes for excessive lengths of stay in all participating wards using an ad hoc data collection sheet. In the wards randomized to the experimental group, interventions aimed to clinician empowerment - provision of reminders and periodical audits - will be implemented.
  5. Expected results: A reduction in the experimental vs. the control arm unnecessary lengths of stay is expected, although the introduced measures will also presumably lead to improvement in the wards where they are not implemented.

Condition or disease Intervention/treatment Phase
Hospitalization Length of Stay Behavioral: Multicomponent strategy to reduce avoidable length of stay Other: No intervention Phase 3

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3862 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation
Study Start Date : February 2008
Primary Completion Date : February 2009
Study Completion Date : February 2010
Arms and Interventions

Arm Intervention/treatment
Experimental: Intervention Behavioral: Multicomponent strategy to reduce avoidable length of stay

The strategy comprises two integrated components:

  1. Distribution of two monthly reports, one consisting in the list of patients who, through data collection performed, are classified to be present on the ward although their clinical status is considered compatible with discharge; the other featuring individual length of stay profiles for each physician operating in the intervention arm (information taken from administrative data), allowing comparisons with the rest of the medical staff;
  2. Audits performed by professionals of each ward of the intervention arm designed to discuss cases judged to be compatible with discharge. The organization of this work are left to the wards, without any interference from the project team.
No Intervention: Control Other: No intervention
No interventions (reporting, auditing) are planned; nevertheless control ward physicians know study aims and are informed about their patient's data collection.

Outcome Measures

Primary Outcome Measures :
  1. Percentage of patient-days compatible with discharge [ Time Frame: 12 month period [02/2008 - 02/2009] +1 follow up month [02/2010] ]

Secondary Outcome Measures :
  1. Overall length of stay (in days) [ Time Frame: 12 month period [02/2008 - 02/2009] ]
    Overall length of stay = discharge date - admission date

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients present on the participating wards during one of 12 randomly selected index days (one for each month of data collection)

Exclusion Criteria:

  • patients admitted or discharged on the index days
  • patients with length of stay (interview date - admission date) > 90 days
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01422811

Azienda Ospedaliero-Universitaria di Parma
Parma, Italy, 43126
Sponsors and Collaborators
Azienda Ospedaliero-Universitaria di Parma
Regione Emilia-Romagna
Principal Investigator: Caterina Caminiti Azienda Ospedaliero-Universitaria di Parma
More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Caterina Caminiti, Dr., Azienda Ospedaliero-Universitaria di Parma
ClinicalTrials.gov Identifier: NCT01422811     History of Changes
Other Study ID Numbers: aopr-rct-los
First Posted: August 24, 2011    Key Record Dates
Last Update Posted: August 24, 2011
Last Verified: August 2011

Keywords provided by Caterina Caminiti, Azienda Ospedaliero-Universitaria di Parma:
Public health